Not Yet Recruiting
FOLFOX Chemotherapy Combined With Fruquintinib and Serplulimab as First-Line Conversion Therapy for Initially Unresectable pMMR/MSS Colorectal Cancer
NCT07446465
- Conditions
- Colonic Diseases, Colorectal Cancer (Locally Advanced or Metastatic), Colorectal Cancer Microsatellite Stable (MSS), +14 more
- Locations
-
- Fudan University Shanghai Cancer Center Shanghai, Xuhui, China